TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Unknown

Using DBS to Probe Basal Ganglia Dysfunction

This study will probe the function of collections of neurons deep in the brain termed the basal ganglia It will investigate the role of the basal ganglia in how and why movement is disrupted in conditions like Parkinson's disease, Dystonia

Oxford, United KingdomView details
CompletedPhase 3

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

The primary purpose of this study is to determine whether sumanirole is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease.

Hot Springs, Arkansas, United States+101 moreView details
CompletedN/A

The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms

This is a 10-week randomized, controlled study to compare the safety and efficacy of two common fiber supplements, psyllium and wheat bran in terms of changes in body weight, nutrition status, and bowel function in patients with Parkinson's

Gainesville, Florida, United StatesView details
CompletedN/A

Thoracolumbar Brace for Individuals With Parkinson's Disease

This pilot study looked to see if a new brace would change the way people with Parkinson's Disease positioned their bodies. It also gathered information on the experience of wearing the brace.

Multiple locationsView details
Completed

Hippotherapy and Parkinson's Disease

BACKGROUND: Motor symptoms associated with Parkinson's disease may impair one's independence and ability to perform daily activities consequently decreases quality of life. Hippotherapy has been shown as an effective treatment to improve fu

Multiple locationsView details
CompletedN/A

Stimulation of the Rostral Zona Incerta for Parkinson's Disease

Patients with Parkinson's Disease who undergo Deep Brain Stimulation surgery receive symptom relief due to electrical stimulation of the brain. The target for the stimulation, in many cases, is the subthalamic nucleus (STN).

Aurora, Colorado, United StatesView details
Completed

Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease

The cause of Parkinson's disease (PD) is currently unknown. Both environmental and genetic factors have been found to contribute to PD pathogenesis.

Chicago, Illinois, United StatesView details
CompletedPhase 3

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.003 trial

Birmingham, Alabama, United States+74 moreView details
CompletedN/A

Neural Signatures of Parkinson's Disease

The purpose of this study is to provide objective measurements of abnormal movements of the body in correlation with neural activity of the brain and track how these change over time. This may allow for the development of objective evaluati

Stanford, California, United StatesView details
UnknownPhase 4

Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease

The cognitive impairment of Parkinson's disease is non amnestic, which is characterized by working memory impairment and executive dysfunction. The current drug therapy (such as levodopa, dopamine receptor agonists) and surgical treatment (

Beijing, ChinaView details
Completed

The Impact of a Diagnosis of Parkinson's on Work

Parkinson's disease leads to loss of employment on average within less than 10 years of disease onset and has been found to be associated with an increased absence from work. This combined with hospitalisation; use of secondary health servi

Oxford, Oxfordshire, United KingdomView details
CompletedN/A

Two Resistance Training Protocols to Reduce the Risk of Falls in Parkinson's Disease

Parkinson's disease (PD) is a chronic neurodegenerative disorder that is characterized by a multitude of symptoms. Impairments in balance, muscle deficits and increased risk of falls are commonly experienced in PD.The purpose of this study

Waterloo, Ontario, CanadaView details
Unknown

Microbiome Composition and Function Contributes to Cognitive Impairment and Neuroinflammation in Parkinson's Disease

Cognitive impairment is a common non-motor symptom among individuals living with Parkinson's disease (PD). Traditionally, cognitive impairment is thought to reflect disruptions in dopaminergic frontal-striatal systems.

San Bernardino, California, United StatesView details
CompletedPhase 1 / Phase 2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease

This is a Phase I/II randomized, double-blind, placebo-controlled, multiple rising dose study in patients with stable idiopathic Parkinson's disease (PD) to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ITI-214

Atlanta, Georgia, United States+1 moreView details
CompletedN/A

Neuroplasticity in Parkinson´s Disease After Training

This project aims to determine the effects of the HiBalance program on neuroplastic changes in people with mild to moderate Parkinson´s disease. The main hypothesis is that highly challenging exercise will lead to greater gait and balance a

Huddinge, SwedenView details
CompletedPhase 2

GM1 Ganglioside Effects on Parkinson's Disease

The purpose of this trial is to examine the short term effects (24 Weeks) of GM1 on Parkinson's disease (PD) symptoms, as well as the effects of long-term treatment (120 Weeks) with GM1 on disease progression, and to examine the extent to w

Philadelphia, Pennsylvania, United StatesView details
CompletedPhase 3

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

This study evaluates how effective a new formulation of a marketed drug is in increasing the time to onset of dyskinesia (abnormal twisting, writhing movements) in patients with Parkinson's Disease who have been taking levodopa for less tha

Anniston, Alabama, United States+68 moreView details
Unknown

The Epidemiology of Parkinson's Disease in Croatia and the Influence of Genetic Factors and Microbiota on the Progression and Treatment Outcomes of the Disease (GiOPARK)

Parkinson's disease (PD) is the second most common neurodegenerative disease, which affects 2-3% of the general population above 65 years. There are significant differences in incidence depending on geographical location, race, and ethnicit

Rijeka, CroatiaView details
TerminatedN/A

Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.

The purpose of this research study is to evaluate safety and effectiveness of Foot Mechanical stimulation to improving Gait and Gait Related Disorders in Parkinson Disease and Progressive Supranuclear Palsy both stable and with motor fluctu

Cassino, FR, Italy+2 moreView details
Completed

Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study

The objective of this study is to evaluate the effectiveness of Deep Brain Stimulation as an adjunctive treatment for reducing some of the symptoms of advanced, levodopa-responsive Parkinson's disease that are not adequately controlled with

Lyon, France+5 moreView details
Load more trials